Browse > Article
http://dx.doi.org/10.7314/APJCP.2013.14.4.2577

Interleukin-10 Gene Promoter Polymorphisms and Risk of Gastric Cancer in a Chinese Population: Single Nucleotide and Haplotype Analyses  

Pan, Xiong-Fei (Department of Epidemiology, West China School of Public Health, Sichuan University)
Yang, Shu-Juan (Department of Child and Adolescent Health, West China School of Public Health, Sichuan University)
Loh, Marie (Cancer Science Institute of Singapore, National University of Singapore)
Xie, Yao (Department of Epidemiology, West China School of Public Health, Sichuan University)
Wen, Yuan-Yuan (Department of Epidemiology, West China School of Public Health, Sichuan University)
Tian, Zhi (Department of Epidemiology, West China School of Public Health, Sichuan University)
Huang, He (Department of Epidemiology, West China School of Public Health, Sichuan University)
Lan, Hui (Department of Epidemiology, West China School of Public Health, Sichuan University)
Chen, Feng (Department of Epidemiology, West China School of Public Health, Sichuan University)
Soong, Richie (Cancer Science Institute of Singapore, National University of Singapore)
Yang, Chun-Xia (Department of Epidemiology, West China School of Public Health, Sichuan University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.14, no.4, 2013 , pp. 2577-2582 More about this Journal
Abstract
Objectives: Interleukin (IL) -10 is a potent cytokine with a dual ability to immunosuppress or immunostimulate. We aimed to explore the association of IL10 promoter polymorphisms with risk of gastric cancer (GC) in a Han population in Southwestern China. Methods: We enrolled 308 pairs of GC and control subjects from four hospitals and a community between October 2010 and August 2011 in a 1:1 matched case-control design. Demographic information was collected using a designed questionnaire. IL10-592 A>C and IL10-1082 A>G polymorphisms were determined by Sequenom MassARRAY analysis. Results: Patients with GC reported statistically higher proportions of family history of cancer (29.9% versus 10.7%, P<0.01) and alcohol drinking (54.6% versus 43.2%, P<0.01) than did controls. Similar results were observed in comparison between non-cardia GC patients and controls (P<0.01 and P=0.03). Variant genotypes of IL10-592 A>C and IL10-1082 A>G were not associated with overall GC risk (adjusted OR, 0.94, 95% CI, 0.66-1.33; adjusted OR, 1.00, 95% CI, 0.62-1.60). Sub-analysis showed that the IL10-592 AC/CC variant genotype was associated with decreased non-cardia GC risk (adjusted OR, 0.58; 95% CI, 0.36-0.95). No association was found between any of the IL10 haplotypes established from two polymorphisms and risk of non-cardia GC. Conclusions: In conclusion, our data do not link the two SNPs of IL10-592 and IL10-1082 with overall GC risk. We demonstrate that IL10-592 polymorphism is associated with protective effect against non-cardia GC. Our findings may offer insight into risk associated with the development of GC in this region.
Keywords
Gastric cancer; interleukin-10 gene; polymorphism; risk; case-control study;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Akdis M, Burgler S, Crameri R, et al (2011). Interleukins, from 1 to 37, and interferon-gamma: receptors, functions, and roles in diseases. J Allergy Clin Immunol, 127, 701-21 e1-70.   DOI   ScienceOn
2 Alpizar-Alpizar W, Perez-Perez GI, Une C, et al (2005). Association of interleukin-1B and interleukin-1RN polymorphisms with gastric cancer in a high-risk population of Costa Rica. Clin Exp Med, 5, 169-76.   DOI
3 Bai XL, Sun LP, Liu J, et al (2008). Correlation of interleukin-10-1082G/a single nucleotide polymorphism to the risk of gastric cancer in north China: a case-control study [in Chinese]. Chin J Cancer, 27, 35-40.
4 Bertuccio P, Chatenoud L, Levi F, et al (2009). Recent patterns in gastric cancer: a global overview. Int J Cancer, 125, 666-73.   DOI   ScienceOn
5 Blaser MJ (1999). Hypothesis: the changing relationships of Helicobacter pylori and humans: implications for health and disease. J Infect Dis, 179, 1523-30.   DOI   ScienceOn
6 Brown LM, Devesa SS (2002). Epidemiologic trends in esophageal and gastric cancer in the United States. Surg Oncol Clin N Am, 11, 235-56.
7 Con SA, Takeuchi H, Con-Chin GR, et al (2009). Role of bacterial and genetic factors in gastric cancer in Costa Rica. World J Gastroenterol, 15, 211-8.   DOI
8 Crawley E, Kay R, Sillibourne J, et al (1999). Polymorphic haplotypes of the interleukin-10 5' flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum, 42, 1101-8.   DOI   ScienceOn
9 Crew KD, Neugut AI (2006). Epidemiology of gastric cancer. World J Gastroenterol, 12, 354-62.
10 El-Omar EM, Rabkin CS, Gammon MD, et al (2003). Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology, 124, 1193-201.   DOI   ScienceOn
11 Ferlay J, Shin HR, Bray F, et al GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet], Lyon, France: International Agency for Research on Cancer; 2010. Available from: http://globocan. iarc.fr, accessed on 25/2/2013.
12 Gibson AW, Edberg JC, Wu J, et al (2001). Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J Immunol, 166, 3915-22.   DOI
13 Guo W, Wang N, Wang YM, et al (2005). Interleukin-10-1082 promoter polymorphism is not associated with susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma in a population of high-incidence region of north China. World J Gastroenterol, 11, 858-62.   DOI
14 Li Z, Zhang Z, He Z, et al (2009). A partition-ligationcombination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis (http://analysis.bio-x.cn). Cell Res, 19, 519-23.   DOI   ScienceOn
15 Jemal A, Center MM, Desantis C, Ward EM (2010). Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev, 19, 1893-907.   DOI   ScienceOn
16 Justenhoven C, Hamann U, Pesch B, et al (2004). ERCC2 genotypes and a corresponding haplotype are linked with breast cancer risk in a German population. Cancer Epidem Biomar, 13, 2059-64.
17 Kamangar F, Dores GM, Anderson WF (2006). Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol, 24, 2137-50.   DOI   ScienceOn
18 Liu J, Song B, Wang JL, et al (2011). Polymorphisms of interleukin-10 promoter are not associated with prognosis of advanced gastric cancer. World J Gastroenterol, 17, 1362-7.   DOI   ScienceOn
19 Loh M, Koh KX, Yeo BH, et al (2009). Meta-analysis of genetic polymorphisms and gastric cancer risk: variability in associations according to race. Eur J Cancer, 45, 2562-8.   DOI   ScienceOn
20 Lu W, Pan K, Zhang L, et al (2005). Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor {alpha} and risk of gastric cancer in a Chinese population. Carcinogenesis, 26, 631-6.
21 Mccoll KE, El-Omar E, Gillen D (2000). Helicobacter pylori gastritis and gastric physiology. Gastroenterol Clin North Am, 29, 687-703, viii.   DOI   ScienceOn
22 Mocellin S, Marincola FM, Young HA (2005). Interleukin-10 and the immune response against cancer: a counterpoint. J Leukoc Biol, 78, 1043-51.   DOI   ScienceOn
23 Salazar-Onfray F, Lopez MN, Mendoza-Naranjo A (2007). Paradoxical effects of cytokines in tumor immune surveillance and tumor immune escape. Cytokine Growth Factor Rev, 18, 171-82.   DOI   ScienceOn
24 Ni P, Xu H, Xue H, et al (2012). A meta-analysis of interleukin-10-1082 promoter polymorphism associated with gastric cancer risk. DNA Cell Biol, 31, 582-91.   DOI   ScienceOn
25 Niven DJ, Berthiaume LR, Fick GH, Laupland KB (2012). Matched case-control studies: a review of reported statistical methodology. Clin Epidemiol, 4, 99-110.
26 Rad R, Dossumbekova A, Neu B, et al (2004). Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection. Gut, 53, 1082-9.   DOI   ScienceOn
27 Seno H, Satoh K, Tsuji S, et al (2007). Novel interleukin-4 and interleukin-1 receptor antagonist gene variations associated with non-cardia gastric cancer in Japan: Comprehensive analysis of 207 polymorphisms of 11 cytokine genes. J Gastroenterol Hepatol, 22, 729-37.   DOI   ScienceOn
28 Shi YY, He L (2005). SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res, 15, 97-8.   DOI   ScienceOn
29 Shin CM, Kim N, Lee HS, et al (2011). Intrafamilial aggregation of gastric cancer: a comprehensive approach including environmental factors, Helicobacter pylori virulence, and genetic susceptibility. Eur J Gastroenterol Hepatol, 23, 411-7.   DOI
30 Sicinschi LA, Lopez-Carrillo L, Camargo MC, et al (2006). Gastric cancer risk in a Mexican population: role of Helicobacter pylori CagA positive infection and polymorphisms in interleukin-1 and-10 genes. Int J Cancer, 118, 649-57.   DOI   ScienceOn
31 Won HH, Kim JW, Kim MJ, et al (2010). Interleukin 10 polymorphisms differentially influence the risk of gastric cancer in East Asians and Caucasians. Cytokine, 51, 73-7.   DOI   ScienceOn
32 Turner DM, Williams DM, Sankaran D, et al (1997). An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet, 24, 1-8.   DOI   ScienceOn
33 Wang J, Ding Q, Shi Y, et al (2012). The interleukin-10-1082 promoter polymorphism and cancer risk: a meta-analysis. Mutagenesis, 27, 305-12.   DOI   ScienceOn
34 Wen YY, Pan XF, Loh M, et al (2012). ADPRT Val762Ala and XRCC1 Arg194Trp polymorphisms and risk of gastric cancer in Sichuan of China. Asian Pac J Cancer Prev, 13, 2139-44.   DOI   ScienceOn
35 Wu MS, Wu CY, Chen CJ, et al (2003). Interleukin-10 genotypes associate with the risk of gastric carcinoma in Taiwanese Chinese. Int J Cancer, 104, 617-23.   DOI   ScienceOn
36 Yuzhalin A (2011). The role of interleukin DNA polymorphisms in gastric cancer. Hum Immunol, 72, 1128-36.   DOI   ScienceOn
37 Zambon CF, Basso D, Navaglia F, et al (2005). Pro-and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome. Cytokine, 29, 141-52.   DOI   ScienceOn
38 Zhou Y, Hu W, Zhuang W, Wu X (2011). Interleukin-10-1082 promoter polymorphism and gastric cancer risk in a Chinese Han population. Mol Cell Biochem, 347, 89-93.   DOI
39 Zhuang W, Wu XT, Zhou Y, et al (2010). Interleukin10-592 promoter polymorphism associated with gastric cancer among Asians: a meta-analysis of epidemiologic studies. Dig Dis Sci, 55, 1525-32.   DOI